---
title: "Tricuspid Valve Disease ‚Äì Repair and Valve Implantation"
description: "Expert evaluation and treatment of tricuspid valve disease in Istanbul. Medical therapy, surgical repair/replacement, and modern transcatheter options for selected patients."
date: 2024-01-15
lastmod: 2025-12-14
draft: false
service_type: "MedicalProcedure"
medical_specialty: "Cardiology"
procedure_type: "TherapeuticProcedure"
body_location: "Heart"
translationKey: "tricuspid-valve"
showBreadcrumbs: true
showTableOfContents: true
showReadingTime: true
faq:
  - question: "Is tricuspid regurgitation serious?"
    answer: "Severe tricuspid regurgitation can lead to progressive right-sided heart failure and reduced quality of life. Treatment options are tailored after a comprehensive evaluation."
  - question: "Do I always need surgery for tricuspid valve disease?"
    answer: "Not always. Depending on the cause and severity, medical therapy, rhythm/lead management, surgical repair/replacement, or transcatheter procedures may be considered."
  - question: "How are transcatheter tricuspid procedures performed?"
    answer: "They are typically performed through a vein in the groin (femoral vein) under advanced imaging guidance, often transesophageal echocardiography (TEE)."
  - question: "What symptoms suggest worsening tricuspid regurgitation?"
    answer: "Leg swelling, abdominal distension (ascites), fatigue, and shortness of breath on exertion are common symptoms."
  - question: "How is the best treatment option chosen?"
    answer: "Treatment is decided based on valve anatomy, right ventricular function, pulmonary pressures, comorbidities, and overall procedural risk‚Äîoften through a multidisciplinary heart team." 
---

{{< alert type="info" >}}
This content has been prepared for informational purposes to protect public health, in compliance with the regulations of the Ministry of Health of the Republic of Turkey and medical ethical rules. It does not provide any diagnosis, treatment guarantees, or specific medical advice. Please consult a qualified healthcare provider for the most accurate information.
{{< /alert >}}

The **tricuspid valve** sits between the **right atrium** and the **right ventricle** and ensures one‚Äëway blood flow. In tricuspid valve disease, the most common problem is **tricuspid regurgitation (leakage)**; **tricuspid stenosis (narrowing)** is less frequent.

This page summarizes the medical background, diagnostic work‚Äëup, and treatment options‚Äîincluding **repair** and **valve implantation/replacement**‚Äîwith an emphasis on **modern transcatheter (catheter‚Äëbased) therapies** for selected patients.

## What Is Tricuspid Valve Disease?

Tricuspid valve disease refers to structural or functional abnormalities that:

- Prevent proper leaflet coaptation and cause **backward leakage** (regurgitation)
- Restrict the valve opening and limit forward flow (**stenosis**)

### Main forms

- **Tricuspid regurgitation (TR):** most common
- **Tricuspid stenosis (TS):** rare
- **Combined disease:** regurgitation and stenosis together

## Tricuspid Regurgitation

### Causes

TR is often classified as **primary (organic)** or **secondary (functional)**.

**Primary (organic) causes:**

- Infective endocarditis
- Rheumatic disease
- Congenital anomalies (e.g., Ebstein anomaly)
- Carcinoid syndrome
- Trauma
- Degenerative leaflet changes

**Secondary (functional) causes (more common):**

- Left‚Äësided heart disease with elevated pulmonary pressures
- Pulmonary hypertension
- Right ventricular dilation/remodeling
- Long‚Äëstanding atrial fibrillation (atrial TR)
- Device leads (pacemaker/ICD) contributing to leaflet dysfunction in selected cases

### Symptoms

- Leg swelling
- Abdominal distension (ascites)
- Fatigue and reduced exercise capacity
- Shortness of breath on exertion
- Prominent neck veins

## Tricuspid Stenosis

Tricuspid stenosis is uncommon. Typical causes include rheumatic disease, carcinoid syndrome, and congenital conditions. Symptoms overlap with right‚Äësided congestion and heart failure.

## Diagnosis: How Is the Tricuspid Valve Evaluated?

The goals are to define **severity**, assess **right‚Äësided chamber impact**, and identify the **underlying mechanism**.

### Clinical evaluation

- Physical examination (murmur, signs of right‚Äësided congestion)
- ECG (rhythm assessment, especially atrial fibrillation)
- Blood tests (kidney/liver function, anemia, biomarkers as appropriate)

### Imaging and hemodynamics

- **Transthoracic echocardiography (TTE):** first‚Äëline tool
- **Transesophageal echocardiography (TEE, often 3D):** detailed anatomy and procedural planning
- **Cardiac MRI:** right ventricular size/function assessment in selected cases
- **Cardiac CT:** annular sizing and anatomical planning when needed
- **Right heart catheterization:** pulmonary pressures/hemodynamics in selected patients

## Treatment Options

Treatment is individualized based on symptoms, TR/TS severity, right ventricular function, pulmonary pressures, valve anatomy, and comorbidities.

### 1) Medical therapy

- **Diuretics** for congestion
- Optimization of heart failure therapy
- Management of underlying drivers (rhythm control for AF when appropriate, treatment of left‚Äësided disease, pulmonary hypertension work‚Äëup, etc.)

Medical therapy can improve symptoms but may not be sufficient in advanced structural disease.

### 2) Surgery: repair or valve replacement

- **Tricuspid valve repair (often preferred):** annuloplasty ring and leaflet techniques when feasible
- **Tricuspid valve replacement (valve implantation):** considered when repair is not feasible or has failed; bioprosthetic options are frequently discussed

### 3) Transcatheter (catheter‚Äëbased) therapies

For selected patients at high surgical risk, minimally invasive transcatheter approaches may be considered:

- **Edge‚Äëto‚Äëedge repair (TEER):** approximation of leaflets to reduce regurgitation (e.g., TriClip / PASCAL)
- **Annuloplasty systems:** device‚Äëbased annular reduction for suitable anatomy
- **Transcatheter tricuspid valve replacement (TTVR):** an option in selected anatomies and clinical settings
- **Caval valve implantation (CAVI):** a palliative approach aimed at reducing venous congestion by placing valve(s) in the venae cavae

Suitability is determined by detailed imaging (often 3D‚ÄëTEE and CT) and multidisciplinary heart‚Äëteam evaluation.

## Pre‚ÄëProcedure Work‚ÄëUp

Common elements include:

- Comprehensive echo (TTE + often TEE)
- Assessment of other valve lesions and coronary disease (when indicated)
- Kidney function and bleeding/thrombotic risk evaluation
- Review of anticoagulants/antiplatelets with individualized planning

## Risks and Recovery

Risk depends on the selected approach (surgical vs transcatheter) and patient factors. Examples include access‚Äësite complications, arrhythmias, bleeding/clotting issues, and incomplete reduction of regurgitation. Recovery is typically faster with transcatheter procedures compared to open surgery.

## Frequently Asked Questions

{{< faq-list >}}

## Appointment and Contact

If you would like to schedule an appointment for tricuspid valve evaluation:

{{< contact-buttons >}}

üìç **Avrasya Hospital** - Be≈ütelsiz Mah. 101. Sokak No:107, Zeytinburnu, Istanbul

üìû **Phone:** +90 212 665 50 50 (Ext: 4012)

---

_This content has been prepared by Assoc. Prof. Dr. Habib √áil for general informational purposes. Please consult a cardiology specialist for definitive diagnosis and treatment._
